Your Partner in Accelerated Drug Discovery

Time kills drug programs. Every month of delay costs money, extends patient suffering, and increases competitive risk. Our platform cuts validation timelines by 30-40%—not by cutting corners, but by doing more in parallel, automating what others do manually, and integrating insights that others silo.

Results in 48-72 hours. Complete MOA insights in weeks, not years.

Testing 5 compounds when you should test 100 isn't just slower—it means you're probably missing the best candidates. Our platform tests hundreds of targets in parallel, giving you the statistical power to find real hits and the confidence to know they're not artifacts.

~100 compounds tested per project vs. ~5 with traditional methods.

The numbers speak for themselves. Our integrated approach—combining genetics, functional genomics, and AI—delivers validated targets at rates traditional methods can't match. Because we characterize mechanism from the start, our targets fail less often in later development.

~75% success rate vs. ~35% with traditional approaches.

Technology is only as good as the people behind it. Our team brings decades of combined experience in genomics, computational biology, drug discovery, and AI/ML. We've built platforms, discovered targets, and developed drugs. Now we're applying everything we've learned to accelerate your programs.

We don't experiment on your projects. Our proprietary integration engines and validated workflows deliver 95%+ data quality, consistently. Every experiment benefits from the thousands that came before it.

Your needs are unique. Choose individual services or comprehensive packages tailored to your discovery goals. Start with a single project or build an ongoing partnership. We adapt to how you work.